Category: Cash

When you start to collect one kind of item, it gets exciting once they all start to come together and there are more than just a few of them. At this point, you may be called an aficionado or connoisseur by others, as your collection starts to swell. The trouble is, should you ever get to the point where you feel like it could be time to cash in and sell your coin collection, how can you know when it is the best time to sell, and how to get the best value?

Collecting coins that are not really for spending carries a similar feel to how foreign currency works, especially when you go on holiday. One day these coins can be worth one amount, and the next day, for whatever reason, they could suddenly be worth a lot less. It can be difficult but not impossible to predict how the markets are likely to fluctuate, and indeed some people have forged successful careers in finance from this talent.

It is easy for specialist collectors to know exactly what a coin is and what it is worth, in the same manner as a jeweler inspecting a gold ring for sell-able value. But how exactly do you know if you have a rare coin just lying about in your pocket, waiting for you to accidentally spend it and offer someone else that chance of collecting it instead?

If you can hold on to a special coin for eons, chances are it would be like winning the lottery or something equally jackpot-worthy. Every now and then, a story appears in the news after some archaeologist or fortunate renovator discovers ancient coins that are definitely not in circulation anywhere else. The hype and value that accompanies this type of find is often fantastic.

The London Mint Office

While these finds are generally fairly uncommon, there are plenty of rare coins you can find. Every so often, the London Mint Office releases commemorative coins to celebrate upcoming events that mark a passage of history. Although many may choose to purchase these when they first come out, after a while the number in circulation will decrease and the value of your coin will begin to rise.

It could well be the case that you’ve picked up one of these without knowing, so before you go rummage through your change jar, the Post Office have released a handy guide, which explains what coins are what, and how many are currently in circulation. At least you know what to look for now.

Once you get started, and realize just how many valuable coins there could be around the world, there is a lot of potential for exciting discoveries along the way. Before you go out and buy a metal detector, and head down to the beach hoping to score some ancient Roman, Bronze Age era coins, you might find that there are many easier ways to start your own coin collection, or cash in on one you didn’t even realize you had.

Medical cannabis-focused Med-X, Inc. has resumed its equity crowdfunding campaign through StartEngine.com in a bid to raise $14.1 million through a minimum $420 per 700 shares.The manufacturer of non-toxic insecticide and pesticide for marijuana cultivators and publisher of The Marijuana Times relaunched the campaign on Sept. 28, 2017 following the lifting of its Securities and Exchange Commission temporary suspension arising from a late filing last year.“We have been qualified bythe SEC and believe we are in full compliance to resume our Regulation A+ crowdfunding efforts once again,” said Chief Operations Officer Matthew Mills.

Med-X Inc. became the first cannabis company to launch a Regulation A+ equity crowdfunding campaign provided in the 2012 JOBS Act. It is also the first company involved with cannabis that StartEngine allowed to raise capital through its platform.”They let us jump on their platform, as we agreed not pursue handling the plant until it’s legal to do so,” said Mills. Mills said FundAmerica is handling the campaign that has raised under $1 million so far.The management team has been diligently working on its business model and continues positioning the company in accordance with its initial plan of operations.”The primary focus will be on the Nature-Cideproduct line for natural pest control in cannabis cultivation, along with the continued development of the popular online cannabis industry publication, The Marijuana Times,” according to Mills.

Nature-Cide

With cities in California and other states legalizing marijuana cultivation and manufacturing, the number of legal indoor pot farms and manufacturing sites for edible products is expected to increase driving demand for improving the quality and safety of local marijuana.Med-X has begun supplying Nature-Cide Pest Management and All-Purpose formulations to the cannabis agricultural and provisioning industries. It is also preparing for distribution its newly developed Nature-Cide insecticidal soil product for all types cultivators. The formulations are a proprietary all-natural essential oil insecticide/miticide/nematicide that repels and kill a wide variety of pests commonly known to damage cannabis crops. Nature-Cide products are listed on the “Approved for use in the Cultivation of Marijuana” by the Colorado, Washington and Oregon state Agriculture Departments. The listing is supported by Med-X’s 18-Month Nature-Cide Integrated Pest Management (IPM) for Cannabis Cultivation Report released in March. “The 18-month report began in 2015 shortly after realizing that the Nature-Cide pesticide products were being recognized by multiple state agricultural departments as a product that is approved for use in medical and recreational marijuana cultivation,” said Mills.

Growth advantage

The legal cannabis industry grew 30 percent in 2016 in North America alone to reach to $6.7 billion because of high growth prospects in the U.S. and Canada, data from Arcview Market Research showed. Arcview is projecting a 25 percent annual growth rate with sales in North American reaching $20.2 billion by 2021. Med-X is in great position to take advantage of the opportunities in the legal cannabis space.While primarily in the business of research and development of commercial medicinal applications of cannabis, Med-X Inc. plans to address other needs required to support the fast-paced emerging cannabis industry, including compound identification and extraction from cannabis oils, along with pharmacy automation beginning with cannabis products and eventually for various pharmaceuticals.According to itsSEC filings, Med-X Inc. plans to cultivate and sell high-quality cannabis for the consumer and commercial markets in areas where it is legal and when they are fully licensed to do so. “Due to our management’s hands-on background in the fields of medicine, large-scale cultivation, commercial pest management as well as operations in internet-based wholesale and retail outlets, we feel we have a tremendous advantage, and can use that skill set to climb into a growth position more rapidly than most,” said Mills.

About Med-X, Inc.

Med-X, Inc. is a Nevada corporation formed in February 2014 to support the fast-paced emerging cannabis industry through such activities as compound identification and extraction of the identified cannabidiol (CBD) compound for the present medical industry demand. The company’s digital magazine, The Marijuana Times, publishes quality media content for the medical cannabis community to generate revenue from advertisers as well as sell industry related merchandise to consumers. The company is ready to bring various products to market in the cannabis, agricultural and ancillary services industries through manufacturing partnerships. For more information regarding Med-X, Inc., please visitwww.medx-rx.com, email info@medx-rx.comor call 818-349-2870.

Medical cannabis-focused Med-X, Inc. has resumed its equity crowdfunding campaign through StartEngine.com in a bid to raise $14.1 million through a minimum $420 per 700 shares.

The manufacturer of non-toxic insecticide and pesticide for marijuana cultivators and publisher of The Marijuana Times relaunched the campaign on Sept. 28, 2017 following the lifting of its Securities and Exchange Commission temporary suspension arising from a late filing last year.

“We have been qualified bythe SEC and believe we are in full compliance to resume our Regulation A+ crowdfunding efforts once again,” said Chief Operations Officer Matthew Mills.

Med-X Inc. became the first cannabis company to launch a Regulation A+ equity crowdfunding campaign provided in the 2012 JOBS Act. It is also the first company involved with cannabis that StartEngine allowed to raise capital through its platform.

“They let us jump on their platform, as we agreed not pursue handling the plant until it’s legal to do so,” said Mills.

Mills said FundAmerica is handling the campaign that has raised under $1 million so far.The management team has been diligently working on its business model and continues positioning the company in accordance with its initial plan of operations.

“The primary focus will be on the Nature-Cideproduct line for natural pest control in cannabis cultivation, along with the continued development of the popular online cannabis industry publication, The Marijuana Times,” according to Mills.

Nature-Cide

With cities in California and other states legalizing marijuana cultivation and manufacturing, the number of legal indoor pot farms and manufacturing sites for edible products is expected to increase driving demand for improving the quality and safety of local marijuana.

Med-X has begun supplying Nature-Cide Pest Management and All-Purpose formulations to the cannabis agricultural and provisioning industries. It is also preparing for distribution its newly developed Nature-Cide insecticidal soil product for all types cultivators. The formulations are a proprietary all-natural essential oil insecticide/miticide/nematicide that repels and kill a wide variety of pests commonly known to damage cannabis crops.

“The 18-month report began in 2015 shortly after realizing that the Nature-Cide pesticide products were being recognized by multiple state agricultural departments as a product that is approved for use in medical and recreational marijuana cultivation,” said Mills.

Growth advantage

The legal cannabis industry grew 30 percent in 2016 in North America alone to reach to $6.7 billion because of high growth prospects in the U.S. and Canada, data from Arcview Market Research showed. Arcview is projecting a 25 percent annual growth rate with sales in North American reaching $20.2 billion by 2021.

Med-X is in great position to take advantage of the opportunities in the legal cannabis space.

While primarily in the business of research and development of commercial medicinal applications of cannabis, Med-X Inc. plans to address other needs required to support the fast-paced emerging cannabis industry, including compound identification and extraction from cannabis oils, along with pharmacy automation beginning with cannabis products and eventually for various pharmaceuticals.

According to itsSEC filings, Med-X Inc. plans to cultivate and sell high-quality cannabis for the consumer and commercial markets in areas where it is legal and when they are fully licensed to do so.

“Due to our management’s hands-on background in the fields of medicine, large-scale cultivation, commercial pest management as well as operations in internet-based wholesale and retail outlets, we feel we have a tremendous advantage, and can use that skill set to climb into a growth position more rapidly than most,” said Mills.

About Med-X, Inc.

Med-X, Inc. is a Nevada corporation formed in February 2014 to support the fast-paced emerging cannabis industry through such activities as compound identification and extraction of the identified cannabidiol (CBD) compound for the present medical industry demand. The company’s digital magazine, The Marijuana Times, publishes quality media content for the medical cannabis community to generate revenue from advertisers as well as sell industry related merchandise to consumers. The company is ready to bring various products to market in the cannabis, agricultural and ancillary services industries through manufacturing partnerships. For more information regarding Med-X, Inc., please visitwww.medx-rx.com, email info@medx-rx.comor call 818-349-2870.

Financial markets can be found in almost every nation in the world. Despite some being very small with only a couple of participants others, such as the New York Stock Exchange and the Forex markets, trade trillions a day. Some of these markets have been open to private investors since they began whilst others decided to maintain the exclusive domain of major international banks and other financial professionals up until the end of the 20th Century.

When it comes to market trading, a financial market is a broad term used to describe a market place where both buyers and sellers get involved in trading assets including equities, bonds, currencies and derivatives and can be recognised by their transparent pricing, basic regulations on trading, costs and feeds as well as their own market forces that determine the prices of securities that trade. In recent years, many of these different financial markets have been affected by changes in technology which is evolving more and more every day.

Capital Markets

A capital market is one where individuals and institutions trade financial securities. Each country has their own capital markets which can vary in size and growth, capital markets in Africa may be different from those in Europe or America. Often, organizations and institutions in both the public and private sector sell securities on the capital markets in an attempt to raise funds.

No matter what, governments and corporations require capital funds to finance their operations in order to pursue their own long term investments. To be able to do this, a company must raise money through the sale of bonds and stocks under the company’s name to be sold and bought in the capital markets.

Stock markets are one of the most important factors of a markets economy as they give companies who have access to the capital and investors the opportunity to gain ownership within the company and identify potential gains based on future performance. Here, investors can buy and sell shares in stock markets between publicly traded companies. Usually the market is divided between the primary and secondary market. Whilst the primary market is the first place where new issues are offered, the secondary market is home to any subsequent trading. The stock market can be volatile at times, particularly when there is political instability within a country, meaning some investors are beginning to worry that there is a calm before the storm on Wall Street this year.

If an investor loans money to a corporate or governmental entity, this is called a bond. It involves borrowing an amount of money for an agreed period time at a secured interest rate. They are used by a number of companies, foreign governments, states and municipalities to fund an array of activities and projects. Bonds can also be bought and sold by investors around the world on credit markets.

Money Market

The money market is just one asset to the financial market where financial instruments that tend to have high liquidity and short maturities are traded between banks or other financial institutions. To put it simply, the money market is used to borrow and lend money for up to just under a year. Whilst investors are prepared to take more risk and tolerance when it comes to investing in capital markets, money markets are a great alternative to hold funds that ae required in a shorter period of time.

Cash or Spot Market

In this highly complex yet vulnerable market, it is a rule that items sold for cash and contracts that are either bought or sold on the market are delivered and implement immediately. Compared to other markets, the cash or “Spot” market prices are established in cash at the current market price whereas other trades are usually settled at forward prices, meaning that those who decide to invest can either be rewarded with a big gain or suffer from a large loss. The New York Stock Exchange is an example of a regulated cash market andthis stock exchange is also a rare example of a market that is safe from automation.

Derivative Markets

The derivative market is called the ‘derivative’ for a reason because its value is acquired based on its underlying asset or assets. Although a derivative is a contract, the contract price is set based on the market price of the core asset. For inexperienced traders seeking to speculate, the derivative market is not ideal due to its complexity but can be used as part of a risk management program protect against the risk of an adverse move.

Forex & Interbank Market

The interbank market is part of the financial system and currency trading performed between banks and financial institutions, not including retail investors and small trading parties. Although some interbank trading is executed between banks on behalf of a large customer, the majority of interbank trading occurs from the banks own account.

The forex market is one of the largest and most liquid markets in the world in terms of the total value traded and exceeds $1.9trillion every day – including all of the currencies in the world today. Although the forex market the largest market in terms of the value traded, any person, firm or county can participate since there is no central marketplace for the exchange of currency to take place. Live Forex trading can be highly beneficial as it allows you to take advantage of the latest updates on the market. However, to succeed at live trading you need to meet certain criteria, including learning how to use the Forex trading software and setting realistic goals before you start.

Primary & Secondary Markets

The primary market is where a majority of investors have their first opportunity to engage in a new security issuance. The funds that are gained from the sale by the issuing company or group is used to fund operations or develop the business where as the secondary market is where investors buy securities or assets from investors as opposed to issuing companies on their own. So essentially, the primary market is the place for new shares and the secondary market is where formerly issued securities must be traded that can be sold multiple times by investors.

The OTC Market

Otherwise called the over-the-counter market, the OTC is a type of secondary market which may be referred to as a dealer market, used to describe stocks that are no longer trading on stock exchange and are usually are traded for companies that don’t fit the criteria to list on a stock exchange. Although OTC market involves trading of financial instruments including stocks, commodities and currencies, it is performed directly between two parties without administration of an exchange.

Third & Fourth Markets

Third and fourth markets usually don’t involve individual investors since they require a significant amount of shares to be negotiated per trade. Instead, the third and further market operates with transactions decided between broker dealers and large institutions through OTC electronic networks. Whilst the third market incorporates OTC transactions between the two, the fourth market is only made up of transactions made between large institutions to avoid placing orders through the main exchange platforms which could significantly increase the cost of the security. The trades carried out by the third and fourth markets will have little, if any effect, on the average investor since both markets are equally as limited.

The purpose of financial institutions and financial markets is to help firms make money by either taking out a loan from and bank and repaying it over a period of time with interest, issue bonds to borrow money from investors to be repaid at specific interest rate or by offering investors part ownership in the company for a claim on its residual cash flow in stock.